109 related articles for article (PubMed ID: 7617069)
41. How important is removal of the parametrium at surgery for carcinoma of the cervix?
Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
Gynecol Oncol; 2002 Jan; 84(1):145-9. PubMed ID: 11748991
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study.
Kristensen GB; Holm R; Abeler VM; Tropé CG
Gynecol Oncol; 1996 Jun; 61(3):378-83. PubMed ID: 8641619
[TBL] [Abstract][Full Text] [Related]
43. Cathepsin B expression and its correlation with tumor-associated laminin and tumor progression in gastric cancer.
Khan A; Krishna M; Baker SP; Malhothra R; Banner BF
Arch Pathol Lab Med; 1998 Feb; 122(2):172-7. PubMed ID: 9499362
[TBL] [Abstract][Full Text] [Related]
44. Correlation of serum sialic acid fractions as markers for carcinoma of the uterine cervix.
Lagana A; Martinez BP; Marino A; Fago G; Bizzarri M
Anticancer Res; 1995; 15(5B):2341-6. PubMed ID: 8572649
[TBL] [Abstract][Full Text] [Related]
45. [Expression of cathepsin B and its clinical importance in colorectal cancer].
Yu B; Li SY; An P; Zuo FY; Cai HY
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Nov; 8(6):507-9. PubMed ID: 16299652
[TBL] [Abstract][Full Text] [Related]
46. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ
Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
[TBL] [Abstract][Full Text] [Related]
47. Cathepsin B and tumor-associated laminin expression in the progression of colorectal adenoma to carcinoma.
Khan A; Krishna M; Baker SP; Banner BF
Mod Pathol; 1998 Aug; 11(8):704-8. PubMed ID: 9720496
[TBL] [Abstract][Full Text] [Related]
48. Glutathione S-transferase pi is expressed in (pre) neoplastic lesions of the human uterine cervix irrespective of their degree of severity.
Martens JE; Smedts F; ter Harmsel B; Helmerhorst TJ; Ramaekers FC
Anticancer Res; 1997; 17(6D):4305-9. PubMed ID: 9494525
[TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix.
Macdonald OK; Chen J; Dodson M; Lee CM; Gaffney DK
Am J Clin Oncol; 2009 Aug; 32(4):411-6. PubMed ID: 19451800
[TBL] [Abstract][Full Text] [Related]
50. Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol.
Reich O; Tamussino K; Lahousen M; Pickel H; Haas J; Winter R
Gynecol Oncol; 2000 Mar; 76(3):331-5. PubMed ID: 10684706
[TBL] [Abstract][Full Text] [Related]
51. Cathepsin B, p53 expression and AgNORs in transitional cell carcinoma.
Akpolat I; Bariş YS; Yilmaz AF; Bakirtaş M; Saylik A; Karagöz F; Kandemir B
Neoplasma; 1998; 45(6):365-8. PubMed ID: 10210109
[TBL] [Abstract][Full Text] [Related]
52. Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix.
Roman LD; Felix JC; Muderspach LI; Varkey T; Burnett AF; Qian D; Morrow CP
Gynecol Oncol; 1998 Mar; 68(3):220-5. PubMed ID: 9570969
[TBL] [Abstract][Full Text] [Related]
53. Value of preoperative serum CA125 in early-stage adenocarcinoma of the uterine cervix without pelvic lymph node metastasis.
Tsai CC; Liu YS; Huang EY; Huang SC; Chang HW; Tseng CW; ChangChien CC
Gynecol Oncol; 2006 Mar; 100(3):591-5. PubMed ID: 16290001
[TBL] [Abstract][Full Text] [Related]
54. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
Aoki Y; Sasaki M; Watanabe M; Sato T; Tsuneki I; Aida H; Tanaka K
Gynecol Oncol; 2000 May; 77(2):305-9. PubMed ID: 10785483
[TBL] [Abstract][Full Text] [Related]
55. Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer.
Horn LC; Fischer U; Raptis G; Bilek K; Hentschel B
Gynecol Oncol; 2007 Nov; 107(2):310-5. PubMed ID: 17826822
[TBL] [Abstract][Full Text] [Related]
56. Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection. A pilot study.
Kridelka FJ; Berg DO; Neuman M; Edwards LS; Robertson G; Grant PT; Hacker NF
Cancer; 1999 Nov; 86(10):2059-65. PubMed ID: 10570432
[TBL] [Abstract][Full Text] [Related]
57. Analysis of the prognostic impact of tumor embolization before definitive radiotherapy for cervical carcinoma.
Kapp KS; Poschauko J; Tauss J; Berghold A; Oechs A; Lahousen M; Petru E; Winter R; Kapp DS
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1399-404. PubMed ID: 16029799
[TBL] [Abstract][Full Text] [Related]
58. Detection of cathepsin B in tumor cytosol and urine of breast cancer patients.
Dengler R; Lah T; Gabrijelcic D; Turk V; Fritz H; Emmerich B
Biomed Biochim Acta; 1991; 50(4-6):555-60. PubMed ID: 1801722
[TBL] [Abstract][Full Text] [Related]
59. Cathepsin B may be a potential biomarker in cervical cancer.
Wu D; Wang H; Li Z; Wang L; Zheng F; Jiang J; Gao Y; Zhong H; Huang Y; Suo Z
Histol Histopathol; 2012 Jan; 27(1):79-87. PubMed ID: 22127599
[TBL] [Abstract][Full Text] [Related]
60. Decreased amniotic fluid peroxidase in malignancy of the cervix.
Armstrong D; Van Wormer D; Dimmitt S
Cancer Biochem Biophys; 1977; 2(1):1-4. PubMed ID: 616316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
